Vitality Portfolio (MSVEX) is an MF managed by Morgan Stanley. Its largest position is ARGENX SE (ARGX), representing 8.03% of fund assets.
Vitality Portfolio Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- MSVEX
- Type:
- MF
- Manager:
- Morgan Stanley
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ARGENX SE
|
8.03% | $171,608.75 | 235 |
|
-
ELI LILLY & Co
|
7.79% | $166,478.37 | 181 |
|
-
Ascendis Pharma A/S
|
5.48% | $117,109.76 | 512 |
|
-
NEKTAR THERAPEUTICS
|
4.75% | $101,593.40 | 1,412 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
4.28% | $91,424.58 | 186 |
|
-
ALIGN TECHNOLOGY INC
|
4.18% | $89,315.03 | 521 |
|
-
Enliven Therapeutics, Inc.
|
3.90% | $83,339.20 | 2,126 |
|
-
10x Genomics, Inc.
|
3.77% | $80,695.23 | 3,801 |
|
-
NEWAMSTERDAM PHARMA CO NV
|
3.57% | $76,279.83 | 2,383 |
|
-
Structure Therapeutics Inc.
|
3.36% | $71,769.80 | 1,489 |
|
-
Ceribell, Inc.
|
3.36% | $71,761.95 | 3,915 |
|
-
Doximity, Inc.
|
2.93% | $62,630.40 | 2,688 |
|
-
INTUITIVE SURGICAL INC
|
2.85% | $60,850.68 | 132 |
|
-
Guardant Health, Inc.
|
2.73% | $58,285.47 | 631 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
2.71% | $57,902.25 | 175 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
2.67% | $57,157.12 | 128 |
|
-
Vaxcyte, Inc.
|
2.59% | $55,320.72 | 952 |
|
-
ILLUMINA, INC.
|
2.52% | $53,864.62 | 437 |
|
-
Inspire Medical Systems, Inc.
|
2.48% | $53,127.40 | 1,030 |
|
-
Zoetis Inc.
|
2.27% | $48,584.31 | 411 |
|
-
UNITEDHEALTH GROUP INC
|
2.18% | $46,541.48 | 172 |
|
-
Kymera Therapeutics, Inc.
|
2.08% | $44,476.86 | 534 |
|
-
DEXCOM INC
|
1.99% | $42,515.60 | 677 |
|
-
Beam Therapeutics Inc.
|
1.79% | $38,175.66 | 1,602 |
|
-
WEST PHARMACEUTICAL SERVICES INC
|
1.71% | $36,593.44 | 146 |
|
-
ATAIBECKLEY INC
|
1.63% | $34,893.78 | 9,857 |
|
-
MAXCYTE, INC.
|
1.63% | $34,746.35 | 49,461 |
|
-
VEEVA SYSTEMS INC
|
1.56% | $33,375.40 | 190 |
|
-
MORGAN STANLEY
|
1.53% | $32,706.88 | 32,707 |
|
-
Schrodinger, Inc.
|
1.36% | $28,990.72 | 2,552 |
|
-
Tempus AI, Inc.
|
1.22% | $26,091.94 | 577 |
|
-
Ultragenyx Pharmaceutical Inc.
|
0.74% | $15,880.10 | 758 |
|
-
UNIQURE NV
|
0.57% | $12,197.10 | 746 |
Advertisement (320x50)